by Terry Myerson, CEO | Jan 13, 2025 | News
Since Truveta’s inception 5 years ago, we have been tirelessly working to build a complete, clean, and timely dataset reflective of US health. Truveta Data now includes 120M de-identified patients’ medical records updated daily. It’s been incredible to work with the...
by Truveta News | Jan 13, 2025 | News
Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announce the Truveta Genome Project, an innovative collaboration to generate genetic data on tens of millions of...
by Truveta News | Jan 9, 2025 | News
Truveta was named a gold winner in Most Innovative Company of the Year for medium-sized companies (100-999 employees) in the Best in Biz Awards 2024, the only independent business awards program judged by editors and reporters from North American publications. The...
by Truveta Research | Dec 14, 2024 | Research, Research Insights
First-time amphetamine/dextroamphetamine prescription rates remained stable overall, but increased significantly for people 30-44, 45-64, and 65+ years of age. The percentage of prescriptions filled within 5 days of being written reached their lowest values in March...
by Truveta Research | Dec 11, 2024 | Research, Research Insights
The rate of first-time ADHD diagnoses has increased since 2021. The largest increases in first-time ADHD diagnosis rates were seen in the 30-44-year-old and 45-64-year-old age groups. Age groups under 30 years old did not see increases in first-time ADHD diagnosis...
